COYA Insider Trading Activity and SEC Form 4 Filings
COYA insider trading summary
No open-market insider purchases or sales of Coya Therapeutics, Inc. (COYA) have been reported on SEC Form 4 in the past 12 months.
Latest COYA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 14, 2024 | David S Snyder | Chief Financial Officer | Buy | $13K (1,800 @ $7.19) |
| Nov 13, 2024 | Arun Swaminathan | Chief Executive Officer | Buy | $37K (5,000 @ $7.36) |
| Nov 11, 2024 | Fred Grossman | Chief Medical Officer | Buy | $20K (2,710 @ $7.37) |
| Nov 11, 2024 | Arun Swaminathan | Chief Executive Officer | Buy | $37K (5,000 @ $7.34) |
| Aug 22, 2023 | Ann Lee | Director | Buy | $4K (1,000 @ $3.62) |
| Jan 3, 2023 | Dov A Md Goldstein | Director | Buy | $0 (10,000 @ $0.00) |
| Jan 3, 2023 | David S Snyder | Chief Financial Officer | Buy | $0 (7,000 @ $0.00) |
| Jan 3, 2023 | Adrian Hepner | Chief Medical Officer | Buy | $0 (10,000 @ $0.00) |
| Jan 3, 2023 | Ann Lee | Director | Buy | $0 (10,000 @ $0.00) |
| Jan 3, 2023 | Hideki Garren | Director | Buy | $0 (2,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.